ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
vTv Therapeutics Inc

vTv Therapeutics Inc (VTVT)

19,59
-2,12
( -9,74% )
Aktualisiert: 20:06:20

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
19,59
Gebot
19,39
Fragen
21,00
Volumen
8.304
19,44 Tagesbereich 21,93
8,10 52-Wochen-Bereich 30,99
Marktkapitalisierung
Handelsende
21,705
Handelsbeginn
21,93
Letzte Trade
1
@
19.925
Letzter Handelszeitpunkt
20:20:12
Finanzvolumen
US$ 163.552
VWAP
19,6955
Durchschnittliches Volumen (3 Mio.)
15.536
Ausgegebene Aktien
3.189.606
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-3,09
Gewinn pro Aktie (EPS)
-6,35
Erlöse
-
Nettogewinn
-20,25M

Über vTv Therapeutics Inc

vTv Therapeutics Inc operates in the United States healthcare sector. Its key business includes the development of orally administered small molecule drug candidates for the treatment of neurological disorders such as Alzheimer's disease. Its major drug candidate to treat Alzheimer's is azeliragon (... vTv Therapeutics Inc operates in the United States healthcare sector. Its key business includes the development of orally administered small molecule drug candidates for the treatment of neurological disorders such as Alzheimer's disease. Its major drug candidate to treat Alzheimer's is azeliragon (TTP488), an orally administered drug. Its other products include TTP399, type II diabetes drug candidate. TTP399 is also an orally administered drug that targets the glucagon-like peptide-1 receptor. It also has over three additional programs in various stages of clinical development for the prevention of muscle weakness and the treatment of inflammatory disorders. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
vTv Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VTVT. The last closing price for vTv Therapeutics was US$21,71. Over the last year, vTv Therapeutics shares have traded in a share price range of US$ 8,10 to US$ 30,99.

vTv Therapeutics currently has 3.189.606 shares in issue. The market capitalisation of vTv Therapeutics is US$69,23 million. vTv Therapeutics has a price to earnings ratio (PE ratio) of -3.09.

VTVT Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.593.105263157891922.3181624619.47791676CS
45.62540.279269602613.96522.313.48910817.27129461CS
124.3128.206806282715.2822.313.21553616.10144341CS
266.0144.256259204713.5822.312.622298015.25993915CS
5210104.2752867579.5930.998.13424816.88133655CS
156-11.202-36.379579111530.792567.3816274728.68994621CS
260-94.81-82.8758741259114.4205.27.3886642099.07544342CS

VTVT - Frequently Asked Questions (FAQ)

What is the current vTv Therapeutics share price?
The current share price of vTv Therapeutics is US$ 19,59
How many vTv Therapeutics shares are in issue?
vTv Therapeutics has 3.189.606 shares in issue
What is the market cap of vTv Therapeutics?
The market capitalisation of vTv Therapeutics is USD 69,23M
What is the 1 year trading range for vTv Therapeutics share price?
vTv Therapeutics has traded in the range of US$ 8,10 to US$ 30,99 during the past year
What is the PE ratio of vTv Therapeutics?
The price to earnings ratio of vTv Therapeutics is -3,09
What is the reporting currency for vTv Therapeutics?
vTv Therapeutics reports financial results in USD
What is the latest annual profit for vTv Therapeutics?
The latest annual profit of vTv Therapeutics is USD -20,25M
What is the registered address of vTv Therapeutics?
The registered address for vTv Therapeutics is 251 LITTLE FALLS DRIVE, OAKS PKWY, WILMINGTON, DELAWARE, 19808
What is the vTv Therapeutics website address?
The website address for vTv Therapeutics is vtvtherapeutics.com
Which industry sector does vTv Therapeutics operate in?
vTv Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
STAIScanTech AI Systems Inc
US$ 3,7346
(82,18%)
128,74M
EFOIEnergy Focus Inc
US$ 2,0607
(59,74%)
43,58M
KWEKWESST Micro Systems Inc
US$ 0,7274
(55,76%)
224,26M
ADTXAditxt Inc
US$ 0,1025
(46,43%)
640,83M
HCTIHealthcare Triangle Inc
US$ 0,6993
(46,02%)
50,68M
INLFINLIF Limited
US$ 3,41
(-79,12%)
9,42M
BPTHBio Path Holdings Inc
US$ 0,214
(-66,20%)
5,21M
SEPNSepterna Inc
US$ 5,5426
(-57,23%)
5,37M
PTPIPetros Pharmaceuticals Inc
US$ 0,1331
(-54,57%)
22,82M
RSLSReShape Lifesciences Inc
US$ 1,09
(-53,22%)
4,74M
ADTXAditxt Inc
US$ 0,1025
(46,43%)
638,82M
KWEKWESST Micro Systems Inc
US$ 0,7274
(55,76%)
224,05M
PRPHProPhase Labs Inc
US$ 0,4684
(44,12%)
168,12M
INTCIntel Corporation
US$ 26,2218
(11,11%)
147,36M
STAIScanTech AI Systems Inc
US$ 3,7346
(82,18%)
128,55M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock